Provenance du réseau au premier degré de Marc Zemel
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Retia Medical LLC
 Retia Medical LLC Packaged SoftwareTechnology Services Retia Medical LLC is a digital health company that develops advanced hemodynamic solutions for high-risk patients. The company is based in Valhalla, NY, and was founded by Marc Zemel and Ramakrishna Mukkamala. The company's proprietary technology, the Argos Cardiac Output (CO) monitor, provides consistently accurate hemodynamic measurements by analyzing multiple heartbeats (MBA™) and not just a single beat at a time. The Argos CO monitor eliminates the need for costly disposables to monitor each patient and is available at a low, fixed-capital cost. Marc Zemel has been the CEO since incorporation.
1
| Holding Company | Packaged Software | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Marc Zemel via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| RESPIRI LIMITED | Medical Specialties | Chief Executive Officer | |
Bunnell, Inc.
 Bunnell, Inc. Medical SpecialtiesHealth Technology Bunnell, Inc. manufactures and markets medical equipment. Its products include life pulse, whisper jet, patient circuit and life port. Bunnell was founded by J. Bert Bunnell in 1980 and is headquartered in Salt Lake City, UT. | Medical Specialties | Director/Board Member | |
| Vital Trends Technology, Inc. | Director/Board Member | ||
| ColdSteel Laser, Inc. | Chief Executive Officer | ||
OneBreath, Inc.
 OneBreath, Inc. Engineering & ConstructionIndustrial Services Onebreath, Inc. operates as a medical device firm. it develops a ventilator that provides continuous respiratory support for infant through adult patients. The company was founded by Vijayasimha Ajarananda, Bryan E. Loomas, and Matthew John Callaghan and is headquartered in Palo Alto, CA. | Engineering & Construction | Director/Board Member | |
| Androvia, Inc. | Director/Board Member | ||
| Medelex, Inc. | President | ||
Origin Life Sciences, Inc.
 Origin Life Sciences, Inc. BiotechnologyHealth Technology Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member | |
| University of Michigan | College/University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
| Australie | 2 |
Sectorielle
| Health Technology | 4 |
| Distribution Services | 2 |
| Industrial Services | 2 |
| Consumer Services | 2 |
Opérationnelle
| Director/Board Member | 6 |
| Chief Executive Officer | 3 |
| Independent Dir/Board Member | 2 |
| President | 2 |
| Chief Operating Officer | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Jerome Korten | 11 |
- Bourse
- Insiders
- Marc Zemel
- Connexions Sociétés
